Om

Adagio Medical Holdings, Inc. is a medical technology company focused on developing and commercializing catheter-based ablation systems for the treatment of cardiac arrhythmias. Its current portfolio includes the iCLAS atrial ultra-low temperature ablation system, the vCLAS ventricular ultra-low temperature catheter platform, and Cryopulse pulsed field cryoablation catheters. These technologies are designed to support physicians treating rhythm disorders such as atrial fibrillation and ventricular tachycardia, with an emphasis on delivering targeted lesion creation in cardiac tissue. Adagio Medical Holdings, Inc. operates as a healthcare device company serving the electrophysiology market, where catheter ablation plays an important role in minimally invasive heart rhythm management. Headquartered in Laguna Hills, California, the company concentrates on clinical and commercial use cases across cardiac arrhythmia care.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ADAGIO MEDICAL HOLDINGS MED ENDAVU: Køb Adagio Medical Holdings ($ADGM) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Adagio Medical Holdings, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.